CM Life Sciences, Inc. Unit
CMLFU
CMLFU was delisted on the 22nd of July, 2021.
17 hedge funds and large institutions have $80.6M invested in CM Life Sciences, Inc. Unit in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less capital invested
Capital invested by funds: $94.8M → $80.6M (-$14.2M)
19% less funds holding
Funds holding: 21 → 17 (-4)
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Rockefeller Capital Management
New York
|
+$375K |
| 2 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$208K |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$6.58M |
| 2 |
ACM
Arrow Capital Management
New York
|
-$1.73M |
| 3 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$860K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$823K |
| 5 |
VF
Virtu Financial
New York
|
-$510K |
CMLFU Hedge Fund Activity: Q2 2021 in Review
17 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences, Inc. Unit (CMLFU) for Q2 2021, worth a combined $80.6M — down 15% from $94.8M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CMLFU and 1 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 2 added.
The largest buyer was Rockefeller Capital Management, opening a new position worth an estimated $375K. The largest seller was BlueCrest Capital Management, exiting entirely with an estimated $6.58M sold.
- 17 institutional investors held CM Life Sciences, Inc. Unit (CMLFU) as of Q2 2021, down from 21 in Q1 2021.
- Funds reported $80.6M of CM Life Sciences, Inc. Unit stock for Q2 2021, down 15% quarter-over-quarter.
- 1 fund opened new CM Life Sciences, Inc. Unit positions in Q2 2021 and 5 closed out, a net change of -4 holders.
- The largest CM Life Sciences, Inc. Unit buyer in Q2 2021 was Rockefeller Capital Management, an estimated $375K added.
- The largest CM Life Sciences, Inc. Unit seller in Q2 2021 was BlueCrest Capital Management, an estimated $6.58M sold.
Based on aggregated 13F filings for Q2 2021.